Home
Demo
Sample
Subscription
Contact Us

Home
Demo
Sample
Subscription
Contact Us

Home
Demo
Sample
Subscription
Contact Us

Subscription Form

Name *

Country *

Email ID *

Contact Number

Domain of Interest

Therapy Area of Interest

Indication of Interest

Email

2nd Floor,

123 Kakrola Complex

Sector 15 Dwarka

Dwarka Mor, New Delhi,

INDIA - 110075

To discuss how we can support you, please get in touch via:

intellishots@octavusconsulting.com

Sample Newsalerts

AbbVie Signs a Partner and Option to Acquire Agreement with TeneoOne for its TNB-383B
Roche Reports Results of Venclexta/Venclyxto (venetoclax) in P-III CLL14 Study for CLL
BeiGene and SpringWorks Globally Signs Clinical Agreement to Target Advanced Solid Tumours
AbbVie Reports FDA’s Hold on All Clinical Trials Evaluating Venclexta/Venclyxto (venetoclax) for Multiple Myeloma
Roche to Acquire Spark Therapeutics for $4.3B

Latest Tweets

Octavus ConsultingFollow

Octavus Consulting @consultoctavus·

Wishing you a day filled with joy and blessings, and a wonderful holiday season ahead!

Reply on Twitter 1331969276287221760 Retweet on Twitter 1331969276287221760 Like on Twitter 13319692762872217601 Twitter 1331969276287221760

Contact Us

Name *

Email *

Comment or Message *

Email

Copyright ©2020 IntelliShots | A CI solution from Octavus Consulting